Published in Medical Letter on the CDC and FDA, March 27th, 2000
The public interest group Public Citizen called for the probe into Warner-Lambert/Parke-Davis, charging the company knew of instances of liver problems associated with the drug Rezulin before it went on the market, but delayed informing the FDA.
An FDA spokesman, speaking on condition of anonymity to the Associated Press, said the agency is reviewing the request for an investigation and will take whatever action is appropriate.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.